Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

November 5, 2014

Major Advance for Diabetes Stem Cell Therapy?
Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.
cprThe FGF21 analogue, LY2405319, lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function.
Docosahexaenoic acid has an anti-diabetic effect in streptozotocin-induced diabetic mice. Free full text available in HTML and PDF formats.

October 29, 2014

The Betatrophin Blues.
One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin. Free full text available in HTML and PDF formats.
Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes.
Losing a Grip on the Notion of β-Cell Specificity for Immune Responses in Type 1 Diabetes: Can We Handle the Truth? Free full text available in PDF format.
Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: a nationwide population-based cohort study.
Type 1 Diabetes Surges In White Kids.

October 22, 2014

A Novel Method to Detect Pressure-Induced Sensor Attenuations (PISA) in an Artificial Pancreas.
Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989-2008: little short-term influence of sunshine hours or average temperature.
The Raikas – a unique combination of high prevalence of type 1 diabetes susceptibility genes and near zero incidence of the disease.
Prognostic value of endothelial dysfunction in type 1 diabetes mellitus. Free full text available in HTML and PDF formats.
Do We Need Worms to Promote Immune Health?

October 15, 2014

Generation of Functional Human Pancreatic β Cells In Vitro. See also From stem cells to billions of human insulin-producing cells and Scientist hopes stem cells will lead to diabetes cure.
FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures. See also It May Take Guts to Cure Diabetes.
Time Lag of Glucose From Intravascular to Interstitial Compartment in Type 1 Diabetes.
Absence of Glucagon and Insulin Action Reveals a Role for the Glucagon-like Peptide-1 Receptor in Endogenous Glucose Production.
Estimated insulin sensitivity predicts regression of albuminuria in Type 1 diabetes.
Life expectancy of people with type 1 diabetes in the past and today.

October 8, 2014

Antibodies to islet cell autoantigens, rotaviruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010-2011 winter viral seasons in Israel: a pilot study. See also Viral Infection May Trigger Childhood Diabetes in Utero.
Design and in silico evaluation of an intraperitoneal-subcutaneous (IP-SC) artificial pancreas.
Does Insulin Therapy for Type 1 Diabetes Mellitus Protect Against Alzheimer’s Disease?
Microneedles for Drug Delivery via the Gastrointestinal Tract. Full text PDF available via link. See also New drug-delivery capsule may replace injections.
Clinical and molecular characterization of maturity onset-diabetes of the young caused by hepatocyte nuclear factor-4 alpha mutation: red flags for prediction of the diagnosis.

October 1, 2014

Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Inpatient Trial of an Artificial Pancreas Based on Multiple Model Probabilistic Predictive Control with Repeated Large Unannounced Meals.
Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.
A Novel, Stable, Aqueous Glucagon Formulation Using Ferulic Acid as an Excipient.
Obesity, islet cell autoimmunity and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes.

September 24, 2014

The Impact of Accelerometer Use in Exercise-Associated Hypoglycemia Prevention in Type 1 Diabetes.
Occurrence of Increased Arterial Stiffness in a Cohort of Adult Patients With Type 1 Diabetes Mellitus When Compared to Normoglycemic Controls.
Helminth Infections Decrease Host Susceptibility to Immune-Mediated Diseases. (See also Helminths in Wikipedia.)
C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.
Probiotics Cut Autoimmunity 33% in Infants at Risk for Diabetes.
Did you get the full story about artificial sweeteners and diabetes?

September 17, 2014

Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.
A Remote Monitoring System for Artificial Pancreas Support Is Safe, Reliable, and User Friendly.
Poor Glycemic Control is Associated with Reduced Prostate-Specific Antigen Concentrations in Men with Type 1 Diabetes.
Nine-year longitudinal study of cardiovascular risk factors in Spanish children and adolescents with type 1 diabetes.
Polymorphism of the FTO Gene Influences Body Weight in Children with Type 1 Diabetes without Severe Obesity. Free full text available in HTML and PDF formats.
New Insulin Glargine 300 units�mL−1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 units�mL−1.

September 10, 2014

Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol. Free full text available in HTML and PDF formats.
Multicenter Closed-Loop/Hybrid Meal Bolus Insulin Delivery with Type 1 Diabetes.
Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients with Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC.
Sodium-Glucose Cotransporter 2 Inhibition in Type 1 Diabetes: Simultaneous Glucose Lowering and Renal Protection?
The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial. Free full text available in HTML and PDF formats.
Preserved Beta-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells.
Hypoglycemic seizures and epilepsy in type I diabetes mellitus.

September 3, 2014

Can Executive Impairments be Precipitated by Excessive Glycemic Fluctuations in Early Onset Type 1 Diabetes Mellitus? A Case Study.
Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study.

« Previous
1
…
42
43
44
45
46
…
94
Next »

advertisement

Last Updated: Saturday, June 14, 2025 15:24:09 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Comments
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Phone
This field is for validation purposes and should be left unchanged.